InsidersTradesSigma
Follow the VRX stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on AU AU, under the authority of ASX. Operating in the Health Care sector, VRX has published 3 reports. Market capitalisation: €29.8m. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: PAUL BOYATZIS. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
VRX is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions for patient well-being.